{"transactions":[{"id":4621766,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25176,"kind":"person","name":"Miller Larry Lee","position":1,"cik":"0001603584","reported_name":"Miller Larry Lee","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Class A Common Stock","published_at":"2026-09-17T21:32:17.000Z","date":"2026-08-06","kind":"grant","planned":false,"acquired":true,"shares":3726,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The reported securities represent restricted stock units (\"RSUs\"), each of which represents a contingent right to receive one share of Class A Common Stock."},{"field":"shares","element":"transactionShares","label":"F2","text":"The RSUs vest in substantially equal installments on each of the first three anniversaries of August 1, 2026, subject to the Reporting Person's continued employment through the applicable vesting date."},{"field":"shares","element":"transactionShares","label":"F3","text":"This amendment to the Form 4 filed on August 10, 2026 (the \"Original Form 4\") corrects the number of RSUs granted on August 6, 2026, which was inadvertently understated in the Original Form 4 due to a calculation error. The reported amount in this amendment correctly reflects the number of RSUs granted on August 6, 2026."}],"balance_after":38275,"source":{"system":"sec-edgar","filing":"0001104659-26-108617","document":"tm2625682-1_4aseq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1603584/000110465926108617/tm2625682-1_4aseq1.xml","form_type":"4/A","original_submission_date":"2026-08-10"}},{"id":692275,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25176,"kind":"person","name":"Miller Larry Lee","position":1,"cik":"0001603584","reported_name":"Miller Larry Lee","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Class A Common Stock","published_at":"2026-08-10T20:17:50.000Z","date":"2026-08-06","kind":"grant","planned":false,"acquired":true,"shares":3522,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The reported securities represent restricted stock units (\"RSUs\"), each of which represents a contingent right to receive one share of Class A Common Stock."},{"field":"shares","element":"transactionShares","label":"F2","text":"The RSUs vest in substantially equal installments on each of the first three anniversaries of August 1, 2026, subject to the Reporting Person's continued employment through the applicable vesting date."}],"balance_after":38071,"source":{"system":"sec-edgar","filing":"0001104659-26-093391","document":"tm2622592-6_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000110465926093391/tm2622592-6_4seq1.xml","form_type":"4"}},{"id":694545,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25176,"kind":"person","name":"Miller Larry Lee","position":1,"cik":"0001603584","reported_name":"Miller Larry Lee","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Class A Common Stock","published_at":"2026-08-07T00:11:26.000Z","date":"2026-08-04","kind":"other","planned":false,"acquired":false,"shares":635,"price":36.599,"value":23240.365,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares sold in a broker assisted cashless exercise program to satisfy tax withholding obligations upon the receipt of Class A Common Stock in connection with the vesting and settlement of restricted stock units."}],"balance_after":34549,"source":{"system":"sec-edgar","filing":"0001104659-26-092230","document":"tm2622506-4_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000110465926092230/tm2622506-4_4seq1.xml","form_type":"4"}},{"id":1062781,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25176,"kind":"person","name":"Miller Larry Lee","position":1,"cik":"0001603584","reported_name":"Miller Larry Lee","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Class A Common Stock","published_at":"2025-08-19T20:19:57.000Z","date":"2025-08-15","kind":"grant","planned":false,"acquired":true,"shares":5184,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The reported securities represent restricted stock units (\"RSUs\"), each of which represents a contingent right to receive one share of Class A Common Stock."},{"field":"shares","element":"transactionShares","label":"F2","text":"The RSUs vest in substantially equal installments on each of the first three anniversaries of August 1, 2025, subject to the Reporting Person's continued employment through the applicable vesting date."}],"balance_after":35184,"source":{"system":"sec-edgar","filing":"0001104659-25-080274","document":"tm2523826-8_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000110465925080274/tm2523826-8_4seq1.xml","form_type":"4"}},{"id":1833155,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25176,"kind":"person","name":"Miller Larry Lee","position":1,"cik":"0001603584","reported_name":"Miller Larry Lee","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Restricted Stock Units","published_at":"2023-07-07T20:16:06.000Z","date":"2023-07-05","kind":"grant","planned":false,"acquired":true,"shares":300000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Class A Common Stock."},{"field":"shares","element":"transactionShares","label":"F2","text":"On July 5, 2023, the Compensation Committee approved the grant to the reporting person of 300,000 RSUs subject to performance-based vesting based solely on the Company's stock price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs will vest on June 30, 2027, in increments of 10% (but no less than 20%) (with linear interpolation to apply for achievement between increments) based upon achievement of the arithmetic average of the Company's closing stock price per share for each trading day in the 90 calendar day period ended June 30, 2027 (the \"90-Day Average\") from $20 to $60 and above, subject to the reporting person's continued employment on such date, and subject to earlier vesting upon certain qualifying termination events. None of the RSUs will vest if the 90-Day Average is below $20, and the maximum vesting percentage for the RSUs is 100% for achievement of a 90-Day Average of $60 or above. Vested shares will be delivered to the reporting person within 30 days after vesting, subject to later delivery in the event of certain trading blackout periods."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs will vest on June 30, 2027, in increments of 10% (but no less than 20%) (with linear interpolation to apply for achievement between increments) based upon achievement of the arithmetic average of the Company's closing stock price per share for each trading day in the 90 calendar day period ended June 30, 2027 (the \"90-Day Average\") from $20 to $60 and above, subject to the reporting person's continued employment on such date, and subject to earlier vesting upon certain qualifying termination events. None of the RSUs will vest if the 90-Day Average is below $20, and the maximum vesting percentage for the RSUs is 100% for achievement of a 90-Day Average of $60 or above. Vested shares will be delivered to the reporting person within 30 days after vesting, subject to later delivery in the event of certain trading blackout periods."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F2","text":"On July 5, 2023, the Compensation Committee approved the grant to the reporting person of 300,000 RSUs subject to performance-based vesting based solely on the Company's stock price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"On July 5, 2023, the Compensation Committee approved the grant to the reporting person of 300,000 RSUs subject to performance-based vesting based solely on the Company's stock price."}],"balance_after":300000,"derivative":{"underlying":"Class A Common Stock","underlying_shares":300000},"source":{"system":"sec-edgar","filing":"0001104659-23-079131","document":"tm2320607-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000110465923079131/tm2320607-2_4seq1.xml","form_type":"4"}},{"id":2869855,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25176,"kind":"person","name":"Miller Larry Lee","position":1,"cik":"0001603584","reported_name":"Miller Larry Lee","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Restricted Stock Units","published_at":"2021-02-11T01:01:02.000Z","date":"2021-02-08","kind":"exercise","acquired":false,"shares":250000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Shares were issued in settlement of restricted stock units (\"RSUs\").  Each RSU represented a contingent right to receive one share of Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"RSUs were granted on May 7, 2018, 50,000 RSUs vested on December 31, 2020 and 200,000 performance-based RSUs were cancelled for not meeting the performance requirement. Vested shares were delivered on February 8, 2021."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"RSUs were granted on May 7, 2018, 50,000 RSUs vested on December 31, 2020 and 200,000 performance-based RSUs were cancelled for not meeting the performance requirement. Vested shares were delivered on February 8, 2021."}],"balance_after":0,"derivative":{"underlying":"Class A Common Stock","underlying_shares":250000},"source":{"system":"sec-edgar","filing":"0001104659-21-020033","document":"tm216079d1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000110465921020033/tm216079d1_4seq1.xml","form_type":"4"}},{"id":2869854,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25176,"kind":"person","name":"Miller Larry Lee","position":1,"cik":"0001603584","reported_name":"Miller Larry Lee","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Class A Common Stock","published_at":"2021-02-11T01:01:02.000Z","date":"2021-02-09","kind":"sale","acquired":false,"shares":20000,"price":22.9406,"value":458812.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the RSUs listed in Table II."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $22.59 to $23.20, inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":30000,"source":{"system":"sec-edgar","filing":"0001104659-21-020033","document":"tm216079d1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000110465921020033/tm216079d1_4seq1.xml","form_type":"4"}},{"id":2869853,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25176,"kind":"person","name":"Miller Larry Lee","position":1,"cik":"0001603584","reported_name":"Miller Larry Lee","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Class A Common Stock","published_at":"2021-02-11T01:01:02.000Z","date":"2021-02-08","kind":"exercise","acquired":true,"shares":50000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Shares were issued in settlement of restricted stock units (\"RSUs\").  Each RSU represented a contingent right to receive one share of Class A Common Stock."}],"balance_after":50000,"source":{"system":"sec-edgar","filing":"0001104659-21-020033","document":"tm216079d1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000110465921020033/tm216079d1_4seq1.xml","form_type":"4"}},{"id":3944589,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25176,"kind":"person","name":"Miller Larry Lee","position":1,"cik":"0001603584","reported_name":"Miller Larry Lee","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Restricted Stock Units","published_at":"2018-05-07T22:00:38.000Z","date":"2018-05-07","kind":"grant","acquired":true,"shares":250000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Class A Common Stock."},{"field":"shares","element":"transactionShares","label":"F2","text":"On May 7, 2018, the Compensation Committee approved the grant to the reporting person of 50,000 RSUs subject to time-based vesting and 200,000 RSUs subject to performance-based vesting based solely on the Company's stock price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The time-based RSUs will vest on December 31, 2020, and the performance-based RSUs will vest on December 31, 2020 in increments from 0% to 100% based on the 90-day average of the Company's stock price from $0 to $80 ending on December 31, 2020, in each case so long as the reporting person's employment has not been terminated prior to such date, and in each case subject to earlier vesting upon certain qualifying termination events.  Vested shares will be delivered to the reporting person 30 days after vesting, subject to later delivery in the event of certain trading blackout periods."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The time-based RSUs will vest on December 31, 2020, and the performance-based RSUs will vest on December 31, 2020 in increments from 0% to 100% based on the 90-day average of the Company's stock price from $0 to $80 ending on December 31, 2020, in each case so long as the reporting person's employment has not been terminated prior to such date, and in each case subject to earlier vesting upon certain qualifying termination events.  Vested shares will be delivered to the reporting person 30 days after vesting, subject to later delivery in the event of certain trading blackout periods."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F2","text":"On May 7, 2018, the Compensation Committee approved the grant to the reporting person of 50,000 RSUs subject to time-based vesting and 200,000 RSUs subject to performance-based vesting based solely on the Company's stock price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"On May 7, 2018, the Compensation Committee approved the grant to the reporting person of 50,000 RSUs subject to time-based vesting and 200,000 RSUs subject to performance-based vesting based solely on the Company's stock price."}],"balance_after":250000,"derivative":{"underlying":"Class A Common Stock","underlying_shares":250000},"source":{"system":"sec-edgar","filing":"0001144204-18-025786","document":"tv493282_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000114420418025786/tv493282_4.xml","form_type":"4"}},{"id":4055718,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25176,"kind":"person","name":"Miller Larry Lee","position":1,"cik":"0001603584","reported_name":"Miller Larry Lee","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Option to purchase Common Stock","published_at":"2018-02-16T02:14:46.000Z","date":"2018-02-14","kind":"exercise","acquired":false,"shares":17928,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 4, 2017."}],"balance_after":0,"derivative":{"exercise_price":11.83,"exercise_date":"2012-03-01","expiration_date":"2019-02-28","underlying":"Class A Common Stock","underlying_shares":17928},"source":{"system":"sec-edgar","filing":"0001144204-18-009411","document":"tv486260_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000114420418009411/tv486260_4.xml","form_type":"4"}},{"id":4055717,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25176,"kind":"person","name":"Miller Larry Lee","position":1,"cik":"0001603584","reported_name":"Miller Larry Lee","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Class A Common Stock","published_at":"2018-02-16T02:14:46.000Z","date":"2018-02-14","kind":"sale","acquired":false,"shares":17928,"price":35.19,"value":630886.32,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 4, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $34.73 to $35.60, inclusive."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001144204-18-009411","document":"tv486260_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000114420418009411/tv486260_4.xml","form_type":"4"}},{"id":4055716,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25176,"kind":"person","name":"Miller Larry Lee","position":1,"cik":"0001603584","reported_name":"Miller Larry Lee","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Class A Common Stock","published_at":"2018-02-16T02:14:46.000Z","date":"2018-02-14","kind":"exercise","acquired":true,"shares":17928,"price":11.83,"value":212088.24,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 4, 2017."}],"balance_after":17928,"source":{"system":"sec-edgar","filing":"0001144204-18-009411","document":"tv486260_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000114420418009411/tv486260_4.xml","form_type":"4"}},{"id":4063622,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25176,"kind":"person","name":"Miller Larry Lee","position":1,"cik":"0001603584","reported_name":"Miller Larry Lee","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Option to purchase Common Stock","published_at":"2018-02-14T02:14:00.000Z","date":"2018-02-13","kind":"exercise","acquired":false,"shares":22086,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 4, 2017."}],"balance_after":17928,"derivative":{"exercise_price":11.83,"exercise_date":"2012-03-01","expiration_date":"2019-02-28","underlying":"Class A Common Stock","underlying_shares":22086},"source":{"system":"sec-edgar","filing":"0001144204-18-008232","document":"tv485591_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000114420418008232/tv485591_4.xml","form_type":"4"}},{"id":4063621,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25176,"kind":"person","name":"Miller Larry Lee","position":1,"cik":"0001603584","reported_name":"Miller Larry Lee","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Option to purchase Common Stock","published_at":"2018-02-14T02:14:00.000Z","date":"2018-02-12","kind":"exercise","acquired":false,"shares":18304,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 4, 2017."}],"balance_after":40014,"derivative":{"exercise_price":11.83,"exercise_date":"2012-03-01","expiration_date":"2019-02-28","underlying":"Class A Common Stock","underlying_shares":18304},"source":{"system":"sec-edgar","filing":"0001144204-18-008232","document":"tv485591_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000114420418008232/tv485591_4.xml","form_type":"4"}},{"id":4063620,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25176,"kind":"person","name":"Miller Larry Lee","position":1,"cik":"0001603584","reported_name":"Miller Larry Lee","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Option to purchase Common Stock","published_at":"2018-02-14T02:14:00.000Z","date":"2018-02-09","kind":"exercise","acquired":false,"shares":14182,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 4, 2017."}],"balance_after":58318,"derivative":{"exercise_price":11.83,"exercise_date":"2012-03-01","expiration_date":"2019-02-28","underlying":"Class A Common Stock","underlying_shares":14182},"source":{"system":"sec-edgar","filing":"0001144204-18-008232","document":"tv485591_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000114420418008232/tv485591_4.xml","form_type":"4"}},{"id":4063619,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25176,"kind":"person","name":"Miller Larry Lee","position":1,"cik":"0001603584","reported_name":"Miller Larry Lee","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Class A Common Stock","published_at":"2018-02-14T02:14:00.000Z","date":"2018-02-13","kind":"sale","acquired":false,"shares":22086,"price":35.05,"value":774114.3,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 4, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $34.75 to $35.40, inclusive."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001144204-18-008232","document":"tv485591_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000114420418008232/tv485591_4.xml","form_type":"4"}},{"id":4063618,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25176,"kind":"person","name":"Miller Larry Lee","position":1,"cik":"0001603584","reported_name":"Miller Larry Lee","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Class A Common Stock","published_at":"2018-02-14T02:14:00.000Z","date":"2018-02-13","kind":"exercise","acquired":true,"shares":22086,"price":11.83,"value":261277.38,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 4, 2017."}],"balance_after":22086,"source":{"system":"sec-edgar","filing":"0001144204-18-008232","document":"tv485591_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000114420418008232/tv485591_4.xml","form_type":"4"}},{"id":4063617,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25176,"kind":"person","name":"Miller Larry Lee","position":1,"cik":"0001603584","reported_name":"Miller Larry Lee","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Class A Common Stock","published_at":"2018-02-14T02:14:00.000Z","date":"2018-02-12","kind":"sale","acquired":false,"shares":500,"price":36.22,"value":18110.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 4, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.18 to $36.40, inclusive."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001144204-18-008232","document":"tv485591_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000114420418008232/tv485591_4.xml","form_type":"4"}},{"id":4063616,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25176,"kind":"person","name":"Miller Larry Lee","position":1,"cik":"0001603584","reported_name":"Miller Larry Lee","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Class A Common Stock","published_at":"2018-02-14T02:14:00.000Z","date":"2018-02-12","kind":"exercise","acquired":true,"shares":500,"price":11.83,"value":5915.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 4, 2017."}],"balance_after":500,"source":{"system":"sec-edgar","filing":"0001144204-18-008232","document":"tv485591_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000114420418008232/tv485591_4.xml","form_type":"4"}},{"id":4063615,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25176,"kind":"person","name":"Miller Larry Lee","position":1,"cik":"0001603584","reported_name":"Miller Larry Lee","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Class A Common Stock","published_at":"2018-02-14T02:14:00.000Z","date":"2018-02-12","kind":"sale","acquired":false,"shares":17804,"price":35.61,"value":634000.44,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 4, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.15 to $36.00, inclusive."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001144204-18-008232","document":"tv485591_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000114420418008232/tv485591_4.xml","form_type":"4"}},{"id":4063614,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25176,"kind":"person","name":"Miller Larry Lee","position":1,"cik":"0001603584","reported_name":"Miller Larry Lee","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Class A Common Stock","published_at":"2018-02-14T02:14:00.000Z","date":"2018-02-12","kind":"exercise","acquired":true,"shares":17804,"price":11.83,"value":210621.32,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 4, 2017."}],"balance_after":17804,"source":{"system":"sec-edgar","filing":"0001144204-18-008232","document":"tv485591_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000114420418008232/tv485591_4.xml","form_type":"4"}},{"id":4063613,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25176,"kind":"person","name":"Miller Larry Lee","position":1,"cik":"0001603584","reported_name":"Miller Larry Lee","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Class A Common Stock","published_at":"2018-02-14T02:14:00.000Z","date":"2018-02-09","kind":"sale","acquired":false,"shares":5600,"price":35.69,"value":199864.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 4, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.65 to $35.90, inclusive."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001144204-18-008232","document":"tv485591_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000114420418008232/tv485591_4.xml","form_type":"4"}},{"id":4063612,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25176,"kind":"person","name":"Miller Larry Lee","position":1,"cik":"0001603584","reported_name":"Miller Larry Lee","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Class A Common Stock","published_at":"2018-02-14T02:14:00.000Z","date":"2018-02-09","kind":"exercise","acquired":true,"shares":5600,"price":11.83,"value":66248.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 4, 2017."}],"balance_after":5600,"source":{"system":"sec-edgar","filing":"0001144204-18-008232","document":"tv485591_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000114420418008232/tv485591_4.xml","form_type":"4"}},{"id":4063611,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25176,"kind":"person","name":"Miller Larry Lee","position":1,"cik":"0001603584","reported_name":"Miller Larry Lee","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Class A Common Stock","published_at":"2018-02-14T02:14:00.000Z","date":"2018-02-09","kind":"sale","acquired":false,"shares":8582,"price":35.36,"value":303459.52,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 4, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $34.65 to $35.60, inclusive."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001144204-18-008232","document":"tv485591_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000114420418008232/tv485591_4.xml","form_type":"4"}},{"id":4063610,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25176,"kind":"person","name":"Miller Larry Lee","position":1,"cik":"0001603584","reported_name":"Miller Larry Lee","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Class A Common Stock","published_at":"2018-02-14T02:14:00.000Z","date":"2018-02-09","kind":"exercise","acquired":true,"shares":8582,"price":11.83,"value":101525.06,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 4, 2017."}],"balance_after":8582,"source":{"system":"sec-edgar","filing":"0001144204-18-008232","document":"tv485591_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000114420418008232/tv485591_4.xml","form_type":"4"}},{"id":4208574,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25176,"kind":"person","name":"Miller Larry Lee","position":1,"cik":"0001603584","reported_name":"Miller Larry Lee","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Option to purchase Common Stock","published_at":"2017-09-16T00:09:57.000Z","date":"2017-09-14","kind":"exercise","acquired":false,"shares":5548,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 14, 2016."}],"balance_after":72500,"derivative":{"exercise_price":11.83,"exercise_date":"2012-03-01","expiration_date":"2019-02-28","underlying":"Class A Common Stock","underlying_shares":5548},"source":{"system":"sec-edgar","filing":"0001144204-17-048333","document":"v475283_form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000114420417048333/v475283_form4.xml","form_type":"4"}},{"id":4208573,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25176,"kind":"person","name":"Miller Larry Lee","position":1,"cik":"0001603584","reported_name":"Miller Larry Lee","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Option to purchase Common Stock","published_at":"2017-09-16T00:09:57.000Z","date":"2017-09-13","kind":"exercise","acquired":false,"shares":15891,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 14, 2016."}],"balance_after":78048,"derivative":{"exercise_price":11.83,"exercise_date":"2012-03-01","expiration_date":"2019-02-28","underlying":"Class A Common Stock","underlying_shares":15891},"source":{"system":"sec-edgar","filing":"0001144204-17-048333","document":"v475283_form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000114420417048333/v475283_form4.xml","form_type":"4"}},{"id":4208572,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25176,"kind":"person","name":"Miller Larry Lee","position":1,"cik":"0001603584","reported_name":"Miller Larry Lee","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Class A Common Stock","published_at":"2017-09-16T00:09:57.000Z","date":"2017-09-14","kind":"sale","acquired":false,"shares":5548,"price":36.34,"value":201614.32,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 14, 2016."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.20 to $36.53, inclusive."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001144204-17-048333","document":"v475283_form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000114420417048333/v475283_form4.xml","form_type":"4"}},{"id":4208571,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25176,"kind":"person","name":"Miller Larry Lee","position":1,"cik":"0001603584","reported_name":"Miller Larry Lee","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Class A Common Stock","published_at":"2017-09-16T00:09:57.000Z","date":"2017-09-14","kind":"exercise","acquired":true,"shares":5548,"price":11.83,"value":65632.84,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 14, 2016."}],"balance_after":5548,"source":{"system":"sec-edgar","filing":"0001144204-17-048333","document":"v475283_form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000114420417048333/v475283_form4.xml","form_type":"4"}},{"id":4208570,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25176,"kind":"person","name":"Miller Larry Lee","position":1,"cik":"0001603584","reported_name":"Miller Larry Lee","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Class A Common Stock","published_at":"2017-09-16T00:09:57.000Z","date":"2017-09-13","kind":"sale","acquired":false,"shares":15891,"price":36.46,"value":579385.86,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 14, 2016."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.30 to $36.60, inclusive."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001144204-17-048333","document":"v475283_form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000114420417048333/v475283_form4.xml","form_type":"4"}},{"id":4208569,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25176,"kind":"person","name":"Miller Larry Lee","position":1,"cik":"0001603584","reported_name":"Miller Larry Lee","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Class A Common Stock","published_at":"2017-09-16T00:09:57.000Z","date":"2017-09-13","kind":"exercise","acquired":true,"shares":15891,"price":11.83,"value":187990.53,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 14, 2016."}],"balance_after":15891,"source":{"system":"sec-edgar","filing":"0001144204-17-048333","document":"v475283_form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000114420417048333/v475283_form4.xml","form_type":"4"}},{"id":4211952,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25176,"kind":"person","name":"Miller Larry Lee","position":1,"cik":"0001603584","reported_name":"Miller Larry Lee","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Option to purchase Common Stock","published_at":"2017-09-13T01:39:14.000Z","date":"2017-09-12","kind":"exercise","acquired":false,"shares":21472,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 14, 2016."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The date exercisable for the securities included on this line was previously incorrectly reported. The information in this column reflects the correct date exercisable for Mr. Miller's options to purchase Class A Common Stock."}],"balance_after":93939,"derivative":{"exercise_price":11.83,"exercise_date":"2012-03-01","expiration_date":"2019-02-28","underlying":"Class A Common Stock","underlying_shares":21472},"source":{"system":"sec-edgar","filing":"0001144204-17-047743","document":"v475013_form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000114420417047743/v475013_form4.xml","form_type":"4"}},{"id":4211951,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25176,"kind":"person","name":"Miller Larry Lee","position":1,"cik":"0001603584","reported_name":"Miller Larry Lee","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Option to purchase Common Stock","published_at":"2017-09-13T01:39:14.000Z","date":"2017-09-11","kind":"exercise","acquired":false,"shares":9700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 14, 2016."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The date exercisable for the securities included on this line was previously incorrectly reported. The information in this column reflects the correct date exercisable for Mr. Miller's options to purchase Class A Common Stock."}],"balance_after":115411,"derivative":{"exercise_price":11.83,"exercise_date":"2012-03-01","expiration_date":"2019-02-28","underlying":"Class A Common Stock","underlying_shares":9700},"source":{"system":"sec-edgar","filing":"0001144204-17-047743","document":"v475013_form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000114420417047743/v475013_form4.xml","form_type":"4"}},{"id":4211950,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25176,"kind":"person","name":"Miller Larry Lee","position":1,"cik":"0001603584","reported_name":"Miller Larry Lee","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Option to purchase Common Stock","published_at":"2017-09-13T01:39:14.000Z","date":"2017-09-08","kind":"exercise","acquired":false,"shares":14930,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 14, 2016."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The date exercisable for the securities included on this line was previously incorrectly reported. The information in this column reflects the correct date exercisable for Mr. Miller's options to purchase Class A Common Stock."}],"balance_after":125111,"derivative":{"exercise_price":11.83,"exercise_date":"2012-03-01","expiration_date":"2019-02-28","underlying":"Class A Common Stock","underlying_shares":14930},"source":{"system":"sec-edgar","filing":"0001144204-17-047743","document":"v475013_form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000114420417047743/v475013_form4.xml","form_type":"4"}},{"id":4211949,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25176,"kind":"person","name":"Miller Larry Lee","position":1,"cik":"0001603584","reported_name":"Miller Larry Lee","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Class A Common Stock","published_at":"2017-09-13T01:39:14.000Z","date":"2017-09-12","kind":"sale","acquired":false,"shares":21472,"price":36.45,"value":782654.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 14, 2016."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.20 to $36.65, inclusive."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001144204-17-047743","document":"v475013_form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000114420417047743/v475013_form4.xml","form_type":"4"}},{"id":4211948,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25176,"kind":"person","name":"Miller Larry Lee","position":1,"cik":"0001603584","reported_name":"Miller Larry Lee","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Class A Common Stock","published_at":"2017-09-13T01:39:14.000Z","date":"2017-09-12","kind":"exercise","acquired":true,"shares":21472,"price":11.83,"value":254013.76,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 14, 2016."}],"balance_after":21472,"source":{"system":"sec-edgar","filing":"0001144204-17-047743","document":"v475013_form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000114420417047743/v475013_form4.xml","form_type":"4"}},{"id":4211947,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25176,"kind":"person","name":"Miller Larry Lee","position":1,"cik":"0001603584","reported_name":"Miller Larry Lee","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Class A Common Stock","published_at":"2017-09-13T01:39:14.000Z","date":"2017-09-11","kind":"sale","acquired":false,"shares":9700,"price":36.26,"value":351722.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 14, 2016."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.20 to $36.40, inclusive."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001144204-17-047743","document":"v475013_form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000114420417047743/v475013_form4.xml","form_type":"4"}},{"id":4211946,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25176,"kind":"person","name":"Miller Larry Lee","position":1,"cik":"0001603584","reported_name":"Miller Larry Lee","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Class A Common Stock","published_at":"2017-09-13T01:39:14.000Z","date":"2017-09-11","kind":"exercise","acquired":true,"shares":9700,"price":11.83,"value":114751.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 14, 2016."}],"balance_after":9700,"source":{"system":"sec-edgar","filing":"0001144204-17-047743","document":"v475013_form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000114420417047743/v475013_form4.xml","form_type":"4"}},{"id":4211945,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25176,"kind":"person","name":"Miller Larry Lee","position":1,"cik":"0001603584","reported_name":"Miller Larry Lee","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Class A Common Stock","published_at":"2017-09-13T01:39:14.000Z","date":"2017-09-08","kind":"sale","acquired":false,"shares":14930,"price":36.19,"value":540316.7,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 14, 2016."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.00 to $36.65, inclusive."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001144204-17-047743","document":"v475013_form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000114420417047743/v475013_form4.xml","form_type":"4"}},{"id":4211944,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25176,"kind":"person","name":"Miller Larry Lee","position":1,"cik":"0001603584","reported_name":"Miller Larry Lee","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Class A Common Stock","published_at":"2017-09-13T01:39:14.000Z","date":"2017-09-08","kind":"exercise","acquired":true,"shares":14930,"price":11.83,"value":176621.9,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 14, 2016."}],"balance_after":14930,"source":{"system":"sec-edgar","filing":"0001144204-17-047743","document":"v475013_form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000114420417047743/v475013_form4.xml","form_type":"4"}},{"id":4215149,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25176,"kind":"person","name":"Miller Larry Lee","position":1,"cik":"0001603584","reported_name":"Miller Larry Lee","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Option to purchase Common Stock","published_at":"2017-09-08T01:13:41.000Z","date":"2017-09-07","kind":"exercise","acquired":false,"shares":18825,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 14, 2016."}],"balance_after":140041,"derivative":{"exercise_price":11.83,"exercise_date":"2013-04-29","expiration_date":"2019-02-28","underlying":"Class A Common Stock","underlying_shares":18825},"source":{"system":"sec-edgar","filing":"0001144204-17-047126","document":"v474773_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000114420417047126/v474773_4.xml","form_type":"4"}},{"id":4215148,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25176,"kind":"person","name":"Miller Larry Lee","position":1,"cik":"0001603584","reported_name":"Miller Larry Lee","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Option to purchase Common Stock","published_at":"2017-09-08T01:13:41.000Z","date":"2017-09-06","kind":"exercise","acquired":false,"shares":8587,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 14, 2016."}],"balance_after":158866,"derivative":{"exercise_price":11.83,"exercise_date":"2013-04-29","expiration_date":"2019-02-28","underlying":"Class A Common Stock","underlying_shares":8587},"source":{"system":"sec-edgar","filing":"0001144204-17-047126","document":"v474773_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000114420417047126/v474773_4.xml","form_type":"4"}},{"id":4215147,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25176,"kind":"person","name":"Miller Larry Lee","position":1,"cik":"0001603584","reported_name":"Miller Larry Lee","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Option to purchase Common Stock","published_at":"2017-09-08T01:13:41.000Z","date":"2017-09-05","kind":"exercise","acquired":false,"shares":5047,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 14, 2016."}],"balance_after":167453,"derivative":{"exercise_price":11.83,"exercise_date":"2013-04-29","expiration_date":"2019-02-28","underlying":"Class A Common Stock","underlying_shares":5047},"source":{"system":"sec-edgar","filing":"0001144204-17-047126","document":"v474773_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000114420417047126/v474773_4.xml","form_type":"4"}},{"id":4215146,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25176,"kind":"person","name":"Miller Larry Lee","position":1,"cik":"0001603584","reported_name":"Miller Larry Lee","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Class A Common Stock","published_at":"2017-09-08T01:13:41.000Z","date":"2017-09-07","kind":"sale","acquired":false,"shares":10589,"price":35.96,"value":380780.44,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 14, 2016."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.90 to $36.10, inclusive."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001144204-17-047126","document":"v474773_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000114420417047126/v474773_4.xml","form_type":"4"}},{"id":4215145,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25176,"kind":"person","name":"Miller Larry Lee","position":1,"cik":"0001603584","reported_name":"Miller Larry Lee","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Class A Common Stock","published_at":"2017-09-08T01:13:41.000Z","date":"2017-09-07","kind":"exercise","acquired":true,"shares":10589,"price":11.83,"value":125267.87,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 14, 2016."}],"balance_after":10589,"source":{"system":"sec-edgar","filing":"0001144204-17-047126","document":"v474773_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000114420417047126/v474773_4.xml","form_type":"4"}},{"id":4215144,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25176,"kind":"person","name":"Miller Larry Lee","position":1,"cik":"0001603584","reported_name":"Miller Larry Lee","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Class A Common Stock","published_at":"2017-09-08T01:13:41.000Z","date":"2017-09-07","kind":"sale","acquired":false,"shares":8236,"price":35.68,"value":293860.48,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 14, 2016."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $34.90 to $35.88, inclusive."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001144204-17-047126","document":"v474773_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000114420417047126/v474773_4.xml","form_type":"4"}},{"id":4215143,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25176,"kind":"person","name":"Miller Larry Lee","position":1,"cik":"0001603584","reported_name":"Miller Larry Lee","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Class A Common Stock","published_at":"2017-09-08T01:13:41.000Z","date":"2017-09-07","kind":"exercise","acquired":true,"shares":8236,"price":11.83,"value":97431.88,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 14, 2016."}],"balance_after":8236,"source":{"system":"sec-edgar","filing":"0001144204-17-047126","document":"v474773_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000114420417047126/v474773_4.xml","form_type":"4"}},{"id":4215142,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25176,"kind":"person","name":"Miller Larry Lee","position":1,"cik":"0001603584","reported_name":"Miller Larry Lee","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Class A Common Stock","published_at":"2017-09-08T01:13:41.000Z","date":"2017-09-06","kind":"sale","acquired":false,"shares":8587,"price":34.97,"value":300287.39,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 14, 2016."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $34.70 to $35.20, inclusive."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001144204-17-047126","document":"v474773_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000114420417047126/v474773_4.xml","form_type":"4"}},{"id":4215141,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25176,"kind":"person","name":"Miller Larry Lee","position":1,"cik":"0001603584","reported_name":"Miller Larry Lee","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Class A Common Stock","published_at":"2017-09-08T01:13:41.000Z","date":"2017-09-06","kind":"exercise","acquired":true,"shares":8587,"price":11.83,"value":101584.21,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 14, 2016."}],"balance_after":8587,"source":{"system":"sec-edgar","filing":"0001144204-17-047126","document":"v474773_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000114420417047126/v474773_4.xml","form_type":"4"}},{"id":4215140,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25176,"kind":"person","name":"Miller Larry Lee","position":1,"cik":"0001603584","reported_name":"Miller Larry Lee","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Class A Common Stock","published_at":"2017-09-08T01:13:41.000Z","date":"2017-09-05","kind":"sale","acquired":false,"shares":810,"price":36.49,"value":29556.9,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 14, 2016."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.35 to $36.65, inclusive."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001144204-17-047126","document":"v474773_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000114420417047126/v474773_4.xml","form_type":"4"}},{"id":4215139,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25176,"kind":"person","name":"Miller Larry Lee","position":1,"cik":"0001603584","reported_name":"Miller Larry Lee","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Class A Common Stock","published_at":"2017-09-08T01:13:41.000Z","date":"2017-09-05","kind":"exercise","acquired":true,"shares":810,"price":11.83,"value":9582.3,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 14, 2016."}],"balance_after":810,"source":{"system":"sec-edgar","filing":"0001144204-17-047126","document":"v474773_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000114420417047126/v474773_4.xml","form_type":"4"}},{"id":4215138,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25176,"kind":"person","name":"Miller Larry Lee","position":1,"cik":"0001603584","reported_name":"Miller Larry Lee","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Class A Common Stock","published_at":"2017-09-08T01:13:41.000Z","date":"2017-09-05","kind":"sale","acquired":false,"shares":4237,"price":35.55,"value":150625.35,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 14, 2016."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.20 to $36.10, inclusive."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001144204-17-047126","document":"v474773_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000114420417047126/v474773_4.xml","form_type":"4"}},{"id":4215137,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25176,"kind":"person","name":"Miller Larry Lee","position":1,"cik":"0001603584","reported_name":"Miller Larry Lee","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Class A Common Stock","published_at":"2017-09-08T01:13:41.000Z","date":"2017-09-05","kind":"exercise","acquired":true,"shares":4237,"price":11.83,"value":50123.71,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 14, 2016."}],"balance_after":4237,"source":{"system":"sec-edgar","filing":"0001144204-17-047126","document":"v474773_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000114420417047126/v474773_4.xml","form_type":"4"}},{"id":4328710,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25176,"kind":"person","name":"Miller Larry Lee","position":1,"cik":"0001603584","reported_name":"Miller Larry Lee","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Option to purchase Class A Common Stock","published_at":"2017-05-10T01:00:25.000Z","date":"2017-05-09","kind":"exercise","acquired":false,"shares":32771,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 14, 2016."}],"balance_after":172500,"derivative":{"exercise_price":11.83,"exercise_date":"2013-04-29","expiration_date":"2019-02-28","underlying":"Class A Common Stock","underlying_shares":32771},"source":{"system":"sec-edgar","filing":"0001571049-17-004766","document":"t1701523-f4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000157104917004766/t1701523-f4.xml","form_type":"4"}},{"id":4328709,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25176,"kind":"person","name":"Miller Larry Lee","position":1,"cik":"0001603584","reported_name":"Miller Larry Lee","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Option to purchase Class A Common Stock","published_at":"2017-05-10T01:00:25.000Z","date":"2017-05-08","kind":"exercise","acquired":false,"shares":3218,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 14, 2016."}],"balance_after":205271,"derivative":{"exercise_price":11.83,"exercise_date":"2013-04-29","expiration_date":"2019-02-28","underlying":"Class A Common Stock","underlying_shares":3218},"source":{"system":"sec-edgar","filing":"0001571049-17-004766","document":"t1701523-f4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000157104917004766/t1701523-f4.xml","form_type":"4"}},{"id":4328708,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25176,"kind":"person","name":"Miller Larry Lee","position":1,"cik":"0001603584","reported_name":"Miller Larry Lee","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Option to purchase Class A Common Stock","published_at":"2017-05-10T01:00:25.000Z","date":"2017-05-05","kind":"exercise","acquired":false,"shares":20836,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 14, 2016."}],"balance_after":208489,"derivative":{"exercise_price":11.83,"exercise_date":"2013-04-29","expiration_date":"2019-02-28","underlying":"Class A Common Stock","underlying_shares":20836},"source":{"system":"sec-edgar","filing":"0001571049-17-004766","document":"t1701523-f4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000157104917004766/t1701523-f4.xml","form_type":"4"}},{"id":4328707,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25176,"kind":"person","name":"Miller Larry Lee","position":1,"cik":"0001603584","reported_name":"Miller Larry Lee","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Class A Common Stock","published_at":"2017-05-10T01:00:25.000Z","date":"2017-05-09","kind":"sale","acquired":false,"shares":32771,"price":31.55,"value":1033925.05,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 14, 2016."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.05 to $32.70, inclusive."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001571049-17-004766","document":"t1701523-f4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000157104917004766/t1701523-f4.xml","form_type":"4"}},{"id":4328706,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25176,"kind":"person","name":"Miller Larry Lee","position":1,"cik":"0001603584","reported_name":"Miller Larry Lee","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Class A Common Stock","published_at":"2017-05-10T01:00:25.000Z","date":"2017-05-09","kind":"exercise","acquired":false,"shares":32771,"price":11.83,"value":387680.93,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 14, 2016."}],"balance_after":32771,"source":{"system":"sec-edgar","filing":"0001571049-17-004766","document":"t1701523-f4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000157104917004766/t1701523-f4.xml","form_type":"4"}},{"id":4328705,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25176,"kind":"person","name":"Miller Larry Lee","position":1,"cik":"0001603584","reported_name":"Miller Larry Lee","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Class A Common Stock","published_at":"2017-05-10T01:00:25.000Z","date":"2017-05-08","kind":"sale","acquired":false,"shares":3218,"price":30,"value":96540.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 14, 2016."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001571049-17-004766","document":"t1701523-f4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000157104917004766/t1701523-f4.xml","form_type":"4"}},{"id":4328704,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25176,"kind":"person","name":"Miller Larry Lee","position":1,"cik":"0001603584","reported_name":"Miller Larry Lee","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Class A Common Stock","published_at":"2017-05-10T01:00:25.000Z","date":"2017-05-08","kind":"exercise","acquired":true,"shares":3218,"price":11.83,"value":38068.94,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 14, 2016."}],"balance_after":3218,"source":{"system":"sec-edgar","filing":"0001571049-17-004766","document":"t1701523-f4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000157104917004766/t1701523-f4.xml","form_type":"4"}},{"id":4328703,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25176,"kind":"person","name":"Miller Larry Lee","position":1,"cik":"0001603584","reported_name":"Miller Larry Lee","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Class A Common Stock","published_at":"2017-05-10T01:00:25.000Z","date":"2017-05-05","kind":"sale","acquired":false,"shares":20836,"price":30.15,"value":628205.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 14, 2016."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.00 to $30.45, inclusive."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001571049-17-004766","document":"t1701523-f4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000157104917004766/t1701523-f4.xml","form_type":"4"}},{"id":4328702,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25176,"kind":"person","name":"Miller Larry Lee","position":1,"cik":"0001603584","reported_name":"Miller Larry Lee","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Class A Common Stock","published_at":"2017-05-10T01:00:25.000Z","date":"2017-05-05","kind":"exercise","acquired":true,"shares":20836,"price":11.83,"value":246489.88,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 14, 2016."}],"balance_after":20836,"source":{"system":"sec-edgar","filing":"0001571049-17-004766","document":"t1701523-f4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000157104917004766/t1701523-f4.xml","form_type":"4"}},{"id":4333703,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25176,"kind":"person","name":"Miller Larry Lee","position":1,"cik":"0001603584","reported_name":"Miller Larry Lee","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Option to purchase Class A Common Stock","published_at":"2017-05-05T01:01:38.000Z","date":"2017-05-04","kind":"exercise","acquired":false,"shares":6984,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 14, 2016."}],"balance_after":229325,"derivative":{"exercise_price":11.83,"exercise_date":"2013-04-29","expiration_date":"2019-02-28","underlying":"Class A Common Stock","underlying_shares":6984},"source":{"system":"sec-edgar","filing":"0001571049-17-004478","document":"t1701456_f4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000157104917004478/t1701456_f4.xml","form_type":"4"}},{"id":4333702,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25176,"kind":"person","name":"Miller Larry Lee","position":1,"cik":"0001603584","reported_name":"Miller Larry Lee","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Option to purchase Class A Common Stock","published_at":"2017-05-05T01:01:38.000Z","date":"2017-05-02","kind":"exercise","acquired":false,"shares":11969,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 14, 2016."}],"balance_after":236309,"derivative":{"exercise_price":11.83,"exercise_date":"2013-04-29","expiration_date":"2019-02-28","underlying":"Class A Common Stock","underlying_shares":11969},"source":{"system":"sec-edgar","filing":"0001571049-17-004478","document":"t1701456_f4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000157104917004478/t1701456_f4.xml","form_type":"4"}},{"id":4333701,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25176,"kind":"person","name":"Miller Larry Lee","position":1,"cik":"0001603584","reported_name":"Miller Larry Lee","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Class A Common Stock","published_at":"2017-05-05T01:01:38.000Z","date":"2017-05-04","kind":"sale","acquired":false,"shares":6984,"price":30.26,"value":211335.84,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 14, 2016."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.00 to $30.50, inclusive"}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001571049-17-004478","document":"t1701456_f4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000157104917004478/t1701456_f4.xml","form_type":"4"}},{"id":4333700,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25176,"kind":"person","name":"Miller Larry Lee","position":1,"cik":"0001603584","reported_name":"Miller Larry Lee","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Class A Common Stock","published_at":"2017-05-05T01:01:38.000Z","date":"2017-05-04","kind":"exercise","acquired":true,"shares":6984,"price":11.83,"value":82620.72,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 14, 2016."}],"balance_after":6984,"source":{"system":"sec-edgar","filing":"0001571049-17-004478","document":"t1701456_f4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000157104917004478/t1701456_f4.xml","form_type":"4"}},{"id":4333699,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25176,"kind":"person","name":"Miller Larry Lee","position":1,"cik":"0001603584","reported_name":"Miller Larry Lee","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Class A Common Stock","published_at":"2017-05-05T01:01:38.000Z","date":"2017-05-02","kind":"sale","acquired":false,"shares":11969,"price":30.06,"value":359788.14,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 14, 2016."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.00 to $30.20, inclusive."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001571049-17-004478","document":"t1701456_f4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000157104917004478/t1701456_f4.xml","form_type":"4"}},{"id":4333698,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25176,"kind":"person","name":"Miller Larry Lee","position":1,"cik":"0001603584","reported_name":"Miller Larry Lee","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Class A Common Stock","published_at":"2017-05-05T01:01:38.000Z","date":"2017-05-02","kind":"exercise","acquired":true,"shares":11969,"price":11.83,"value":141593.27,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 14, 2016."}],"balance_after":11969,"source":{"system":"sec-edgar","filing":"0001571049-17-004478","document":"t1701456_f4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000157104917004478/t1701456_f4.xml","form_type":"4"}},{"id":4340689,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25176,"kind":"person","name":"Miller Larry Lee","position":1,"cik":"0001603584","reported_name":"Miller Larry Lee","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Option to purchase Class A Common Stock","published_at":"2017-05-02T01:04:34.000Z","date":"2017-05-01","kind":"exercise","acquired":false,"shares":10383,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 14, 2016."}],"balance_after":248278,"derivative":{"exercise_price":11.83,"exercise_date":"2013-04-29","expiration_date":"2019-02-28","underlying":"Class A Common Stock","underlying_shares":10383},"source":{"system":"sec-edgar","filing":"0001571049-17-004291","document":"t1701363_f4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000157104917004291/t1701363_f4.xml","form_type":"4"}},{"id":4340688,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25176,"kind":"person","name":"Miller Larry Lee","position":1,"cik":"0001603584","reported_name":"Miller Larry Lee","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Option to purchase Class A Common Stock","published_at":"2017-05-02T01:04:34.000Z","date":"2017-04-27","kind":"exercise","acquired":false,"shares":4397,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 14, 2016."}],"balance_after":258661,"derivative":{"exercise_price":11.83,"exercise_date":"2013-04-29","expiration_date":"2019-02-28","underlying":"Class A Common Stock","underlying_shares":4397},"source":{"system":"sec-edgar","filing":"0001571049-17-004291","document":"t1701363_f4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000157104917004291/t1701363_f4.xml","form_type":"4"}},{"id":4340687,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25176,"kind":"person","name":"Miller Larry Lee","position":1,"cik":"0001603584","reported_name":"Miller Larry Lee","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Class A Common Stock","published_at":"2017-05-02T01:04:34.000Z","date":"2017-05-01","kind":"sale","acquired":false,"shares":10383,"price":30.17,"value":313255.11,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 14, 2016."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.00 to $30.45, inclusive"}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001571049-17-004291","document":"t1701363_f4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000157104917004291/t1701363_f4.xml","form_type":"4"}},{"id":4340686,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25176,"kind":"person","name":"Miller Larry Lee","position":1,"cik":"0001603584","reported_name":"Miller Larry Lee","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Class A Common Stock","published_at":"2017-05-02T01:04:34.000Z","date":"2017-05-01","kind":"exercise","acquired":true,"shares":10383,"price":11.83,"value":122830.89,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 14, 2016."}],"balance_after":10383,"source":{"system":"sec-edgar","filing":"0001571049-17-004291","document":"t1701363_f4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000157104917004291/t1701363_f4.xml","form_type":"4"}},{"id":4340685,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25176,"kind":"person","name":"Miller Larry Lee","position":1,"cik":"0001603584","reported_name":"Miller Larry Lee","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Class A Common Stock","published_at":"2017-05-02T01:04:34.000Z","date":"2017-04-27","kind":"sale","acquired":false,"shares":4397,"price":30.02,"value":131997.94,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 14, 2016."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.00 to $30.13, inclusive."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001571049-17-004291","document":"t1701363_f4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000157104917004291/t1701363_f4.xml","form_type":"4"}},{"id":4340684,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25176,"kind":"person","name":"Miller Larry Lee","position":1,"cik":"0001603584","reported_name":"Miller Larry Lee","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Class A Common Stock","published_at":"2017-05-02T01:04:34.000Z","date":"2017-04-27","kind":"exercise","acquired":true,"shares":4397,"price":11.83,"value":52016.51,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 14, 2016."}],"balance_after":4397,"source":{"system":"sec-edgar","filing":"0001571049-17-004291","document":"t1701363_f4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000157104917004291/t1701363_f4.xml","form_type":"4"}},{"id":4443340,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25176,"kind":"person","name":"Miller Larry Lee","position":1,"cik":"0001603584","reported_name":"Miller Larry Lee","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Option to purchase Class A Common Stock","published_at":"2017-02-17T02:30:00.000Z","date":"2017-02-16","kind":"exercise","acquired":false,"shares":367,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 14, 2016."}],"balance_after":263058,"derivative":{"exercise_price":11.83,"exercise_date":"2013-04-29","expiration_date":"2019-02-28","underlying":"Class A Common Stock","underlying_shares":367},"source":{"system":"sec-edgar","filing":"0001571049-17-001432","document":"t1700530_x1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000157104917001432/t1700530_x1.xml","form_type":"4"}},{"id":4443339,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25176,"kind":"person","name":"Miller Larry Lee","position":1,"cik":"0001603584","reported_name":"Miller Larry Lee","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Option to purchase Class A Common Stock","published_at":"2017-02-17T02:30:00.000Z","date":"2017-02-15","kind":"exercise","acquired":false,"shares":940,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 14, 2016."}],"balance_after":263425,"derivative":{"exercise_price":11.83,"exercise_date":"2013-04-29","expiration_date":"2019-02-28","underlying":"Class A Common Stock","underlying_shares":940},"source":{"system":"sec-edgar","filing":"0001571049-17-001432","document":"t1700530_x1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000157104917001432/t1700530_x1.xml","form_type":"4"}},{"id":4443338,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25176,"kind":"person","name":"Miller Larry Lee","position":1,"cik":"0001603584","reported_name":"Miller Larry Lee","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Option to purchase Class A Common Stock","published_at":"2017-02-17T02:30:00.000Z","date":"2017-02-14","kind":"exercise","acquired":false,"shares":3281,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 14, 2016."}],"balance_after":264365,"derivative":{"exercise_price":11.83,"exercise_date":"2013-04-29","expiration_date":"2019-02-28","underlying":"Class A Common Stock","underlying_shares":3281},"source":{"system":"sec-edgar","filing":"0001571049-17-001432","document":"t1700530_x1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000157104917001432/t1700530_x1.xml","form_type":"4"}},{"id":4443337,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25176,"kind":"person","name":"Miller Larry Lee","position":1,"cik":"0001603584","reported_name":"Miller Larry Lee","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Class A Common Stock","published_at":"2017-02-17T02:30:00.000Z","date":"2017-02-16","kind":"sale","acquired":false,"shares":367,"price":30,"value":11010.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 14, 2016."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001571049-17-001432","document":"t1700530_x1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000157104917001432/t1700530_x1.xml","form_type":"4"}},{"id":4443336,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25176,"kind":"person","name":"Miller Larry Lee","position":1,"cik":"0001603584","reported_name":"Miller Larry Lee","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Class A Common Stock","published_at":"2017-02-17T02:30:00.000Z","date":"2017-02-16","kind":"exercise","acquired":true,"shares":367,"price":11.83,"value":4341.61,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 14, 2016."}],"balance_after":367,"source":{"system":"sec-edgar","filing":"0001571049-17-001432","document":"t1700530_x1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000157104917001432/t1700530_x1.xml","form_type":"4"}},{"id":4443335,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25176,"kind":"person","name":"Miller Larry Lee","position":1,"cik":"0001603584","reported_name":"Miller Larry Lee","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Class A Common Stock","published_at":"2017-02-17T02:30:00.000Z","date":"2017-02-15","kind":"sale","acquired":false,"shares":940,"price":30,"value":28200.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 14, 2016."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001571049-17-001432","document":"t1700530_x1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000157104917001432/t1700530_x1.xml","form_type":"4"}},{"id":4443334,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25176,"kind":"person","name":"Miller Larry Lee","position":1,"cik":"0001603584","reported_name":"Miller Larry Lee","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Class A Common Stock","published_at":"2017-02-17T02:30:00.000Z","date":"2017-02-15","kind":"exercise","acquired":true,"shares":940,"price":11.83,"value":11120.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 14, 2016."}],"balance_after":940,"source":{"system":"sec-edgar","filing":"0001571049-17-001432","document":"t1700530_x1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000157104917001432/t1700530_x1.xml","form_type":"4"}},{"id":4443333,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25176,"kind":"person","name":"Miller Larry Lee","position":1,"cik":"0001603584","reported_name":"Miller Larry Lee","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Class A Common Stock","published_at":"2017-02-17T02:30:00.000Z","date":"2017-02-14","kind":"sale","acquired":false,"shares":3281,"price":30,"value":98430.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 14, 2016."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001571049-17-001432","document":"t1700530_x1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000157104917001432/t1700530_x1.xml","form_type":"4"}},{"id":4443332,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25176,"kind":"person","name":"Miller Larry Lee","position":1,"cik":"0001603584","reported_name":"Miller Larry Lee","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Class A Common Stock","published_at":"2017-02-17T02:30:00.000Z","date":"2017-02-14","kind":"exercise","acquired":true,"shares":3281,"price":11.83,"value":38814.23,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 14, 2016."}],"balance_after":3281,"source":{"system":"sec-edgar","filing":"0001571049-17-001432","document":"t1700530_x1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000157104917001432/t1700530_x1.xml","form_type":"4"}},{"id":4454540,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25176,"kind":"person","name":"Miller Larry Lee","position":1,"cik":"0001603584","reported_name":"Miller Larry Lee","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Option to purchase Class A Common Stock","published_at":"2017-02-14T01:33:13.000Z","date":"2017-02-13","kind":"exercise","acquired":false,"shares":22139,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 14, 2016."}],"balance_after":267646,"derivative":{"exercise_price":11.83,"exercise_date":"2013-04-29","expiration_date":"2019-02-28","underlying":"Class A Common Stock","underlying_shares":22139},"source":{"system":"sec-edgar","filing":"0001571049-17-001289","document":"t1700411_x1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000157104917001289/t1700411_x1.xml","form_type":"4"}},{"id":4454539,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25176,"kind":"person","name":"Miller Larry Lee","position":1,"cik":"0001603584","reported_name":"Miller Larry Lee","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Option to purchase Class A Common Stock","published_at":"2017-02-14T01:33:13.000Z","date":"2017-02-10","kind":"exercise","acquired":false,"shares":45528,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 14, 2016."}],"balance_after":289785,"derivative":{"exercise_price":11.83,"exercise_date":"2013-04-29","expiration_date":"2019-02-28","underlying":"Class A Common Stock","underlying_shares":45528},"source":{"system":"sec-edgar","filing":"0001571049-17-001289","document":"t1700411_x1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000157104917001289/t1700411_x1.xml","form_type":"4"}},{"id":4454538,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25176,"kind":"person","name":"Miller Larry Lee","position":1,"cik":"0001603584","reported_name":"Miller Larry Lee","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Option to purchase Class A Common Stock","published_at":"2017-02-14T01:33:13.000Z","date":"2017-02-09","kind":"exercise","acquired":false,"shares":29562,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 14, 2016."}],"balance_after":335313,"derivative":{"exercise_price":11.83,"exercise_date":"2013-04-29","expiration_date":"2019-02-28","underlying":"Class A Common Stock","underlying_shares":29562},"source":{"system":"sec-edgar","filing":"0001571049-17-001289","document":"t1700411_x1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000157104917001289/t1700411_x1.xml","form_type":"4"}},{"id":4454537,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25176,"kind":"person","name":"Miller Larry Lee","position":1,"cik":"0001603584","reported_name":"Miller Larry Lee","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Class A Common Stock","published_at":"2017-02-14T01:33:13.000Z","date":"2017-02-13","kind":"sale","acquired":false,"shares":22139,"price":30.04,"value":665055.56,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 14, 2016."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.00 to $30.55, inclusive."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001571049-17-001289","document":"t1700411_x1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000157104917001289/t1700411_x1.xml","form_type":"4"}},{"id":4454536,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25176,"kind":"person","name":"Miller Larry Lee","position":1,"cik":"0001603584","reported_name":"Miller Larry Lee","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Class A Common Stock","published_at":"2017-02-14T01:33:13.000Z","date":"2017-02-13","kind":"exercise","acquired":true,"shares":22139,"price":11.83,"value":261904.37,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 14, 2016."}],"balance_after":22139,"source":{"system":"sec-edgar","filing":"0001571049-17-001289","document":"t1700411_x1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000157104917001289/t1700411_x1.xml","form_type":"4"}},{"id":4454535,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25176,"kind":"person","name":"Miller Larry Lee","position":1,"cik":"0001603584","reported_name":"Miller Larry Lee","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Class A Common Stock","published_at":"2017-02-14T01:33:13.000Z","date":"2017-02-10","kind":"sale","acquired":false,"shares":45528,"price":30.57,"value":1391790.96,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 14, 2016."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.00 to $30.80, inclusive."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001571049-17-001289","document":"t1700411_x1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000157104917001289/t1700411_x1.xml","form_type":"4"}},{"id":4454534,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25176,"kind":"person","name":"Miller Larry Lee","position":1,"cik":"0001603584","reported_name":"Miller Larry Lee","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Class A Common Stock","published_at":"2017-02-14T01:33:13.000Z","date":"2017-02-10","kind":"exercise","acquired":true,"shares":45528,"price":11.83,"value":538596.24,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 14, 2016."}],"balance_after":45528,"source":{"system":"sec-edgar","filing":"0001571049-17-001289","document":"t1700411_x1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000157104917001289/t1700411_x1.xml","form_type":"4"}},{"id":4454533,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25176,"kind":"person","name":"Miller Larry Lee","position":1,"cik":"0001603584","reported_name":"Miller Larry Lee","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Class A Common Stock","published_at":"2017-02-14T01:33:13.000Z","date":"2017-02-09","kind":"sale","acquired":false,"shares":29562,"price":30.3,"value":895728.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 14, 2016."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.00 to $30.40, inclusive."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001571049-17-001289","document":"t1700411_x1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000157104917001289/t1700411_x1.xml","form_type":"4"}},{"id":4454532,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25176,"kind":"person","name":"Miller Larry Lee","position":1,"cik":"0001603584","reported_name":"Miller Larry Lee","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Class A Common Stock","published_at":"2017-02-14T01:33:13.000Z","date":"2017-02-09","kind":"exercise","acquired":true,"shares":29562,"price":11.83,"value":349718.46,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 14, 2016."}],"balance_after":29562,"source":{"system":"sec-edgar","filing":"0001571049-17-001289","document":"t1700411_x1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000157104917001289/t1700411_x1.xml","form_type":"4"}},{"id":4499393,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25176,"kind":"person","name":"Miller Larry Lee","position":1,"cik":"0001603584","reported_name":"Miller Larry Lee","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Option to purchase Class A Common Stock","published_at":"2017-01-06T01:01:02.000Z","date":"2017-01-03","kind":"exercise","acquired":false,"shares":187,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 14, 2016."}],"balance_after":364875,"derivative":{"exercise_price":11.83,"exercise_date":"2013-04-29","expiration_date":"2019-02-28","underlying":"Class A Common Stock","underlying_shares":187},"source":{"system":"sec-edgar","filing":"0001571049-17-000213","document":"t1700038-x2.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000157104917000213/t1700038-x2.xml","form_type":"4"}},{"id":4499392,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25176,"kind":"person","name":"Miller Larry Lee","position":1,"cik":"0001603584","reported_name":"Miller Larry Lee","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Class A Common Stock","published_at":"2017-01-06T01:01:02.000Z","date":"2017-01-03","kind":"sale","acquired":false,"shares":187,"price":30,"value":5610.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 14, 2016."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001571049-17-000213","document":"t1700038-x2.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000157104917000213/t1700038-x2.xml","form_type":"4"}},{"id":4499391,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25176,"kind":"person","name":"Miller Larry Lee","position":1,"cik":"0001603584","reported_name":"Miller Larry Lee","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Class A Common Stock","published_at":"2017-01-06T01:01:02.000Z","date":"2017-01-03","kind":"exercise","acquired":true,"shares":187,"price":11.83,"value":2212.21,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 14, 2016."}],"balance_after":187,"source":{"system":"sec-edgar","filing":"0001571049-17-000213","document":"t1700038-x2.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000157104917000213/t1700038-x2.xml","form_type":"4"}},{"id":4514439,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25176,"kind":"person","name":"Miller Larry Lee","position":1,"cik":"0001603584","reported_name":"Miller Larry Lee","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Option to purchase Class A Common Stock","published_at":"2016-12-22T02:03:27.000Z","date":"2016-12-20","kind":"exercise","acquired":false,"shares":1540,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 14, 2016."}],"balance_after":365062,"derivative":{"exercise_price":11.83,"exercise_date":"2013-04-29","expiration_date":"2019-02-28","underlying":"Class A Common Stock","underlying_shares":1540},"source":{"system":"sec-edgar","filing":"0001571049-16-020777","document":"t1603145_x2.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000157104916020777/t1603145_x2.xml","form_type":"4"}},{"id":4514438,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25176,"kind":"person","name":"Miller Larry Lee","position":1,"cik":"0001603584","reported_name":"Miller Larry Lee","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Option to purchase Class A Common Stock","published_at":"2016-12-22T02:03:27.000Z","date":"2016-12-19","kind":"exercise","acquired":false,"shares":252,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 14, 2016."}],"balance_after":366602,"derivative":{"exercise_price":11.83,"exercise_date":"2013-04-29","expiration_date":"2019-02-28","underlying":"Class A Common Stock","underlying_shares":252},"source":{"system":"sec-edgar","filing":"0001571049-16-020777","document":"t1603145_x2.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000157104916020777/t1603145_x2.xml","form_type":"4"}},{"id":4514437,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25176,"kind":"person","name":"Miller Larry Lee","position":1,"cik":"0001603584","reported_name":"Miller Larry Lee","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Class A Common Stock","published_at":"2016-12-22T02:03:27.000Z","date":"2016-12-20","kind":"sale","acquired":false,"shares":1540,"price":30.04,"value":46261.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 14, 2016."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.00 to $30.10, inclusive."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001571049-16-020777","document":"t1603145_x2.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000157104916020777/t1603145_x2.xml","form_type":"4"}},{"id":4514436,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25176,"kind":"person","name":"Miller Larry Lee","position":1,"cik":"0001603584","reported_name":"Miller Larry Lee","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Class A Common Stock","published_at":"2016-12-22T02:03:27.000Z","date":"2016-12-20","kind":"exercise","acquired":true,"shares":1540,"price":11.83,"value":18218.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 14, 2016."}],"balance_after":1540,"source":{"system":"sec-edgar","filing":"0001571049-16-020777","document":"t1603145_x2.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000157104916020777/t1603145_x2.xml","form_type":"4"}},{"id":4514435,"issuer":{"id":4671,"kind":"organization","name":"PHIBRO ANIMAL HEALTH CORP","symbol":"PAHC"},"owners":[{"id":25176,"kind":"person","name":"Miller Larry Lee","position":1,"cik":"0001603584","reported_name":"Miller Larry Lee","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Class A Common Stock","published_at":"2016-12-22T02:03:27.000Z","date":"2016-12-19","kind":"sale","acquired":false,"shares":252,"price":30,"value":7560.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 14, 2016."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001571049-16-020777","document":"t1603145_x2.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1069899/000157104916020777/t1603145_x2.xml","form_type":"4"}}],"next_cursor":"2016-12-22T02:03:27.000000Z,4514435"}